Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss

scientific article published on 25 January 2014

Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/OBY.20695
P698PubMed publication ID24415446
P5875ResearchGate publication ID259700953

P50authorHåkan AhlströmQ66190621
Joel KullbergQ91760902
Johanna Helmersson-KarlqvistQ91965697
Viola AdamssonQ114441307
Juan J CarreroQ37828646
Peter StenvinkelQ37828656
Ulf RisérusQ38626286
Karl MichaëlssonQ44118143
Anders LarssonQ59163549
Lars LindQ65992534
P2093author name stringJohan Arnlöv
Anna Witasp
P2860cites workVisceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart StudyQ28219755
ObesityQ28275029
Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul StudyQ34150807
Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cellsQ34180480
Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.Q34184675
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertilityQ34403569
ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolismQ34537657
Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.Q34713240
Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal diseaseQ35664554
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney diseaseQ36736700
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic riskQ37115260
Pentraxins, humoral innate immunity and tissue injuryQ37200012
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndromeQ37309372
Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implicationsQ37944361
Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesityQ39477901
AdipoQ is a novel adipose-specific gene dysregulated in obesityQ42813232
Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndromeQ43181277
Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individualsQ44072391
Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and womenQ44291205
Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortalityQ44571381
Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L.Q44801998
Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populationsQ46071688
Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors.Q46525885
Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men.Q46530614
A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) studyQ46686072
Pentraxin 3: a novel and independent prognostic marker in ischemic stroke.Q48770462
Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET)Q51388639
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.Q51469352
Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men.Q51571487
Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.Q51802963
Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L.Q51906910
Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3.Q53476226
The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.Q53496784
Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial InfarctionQ56942653
P433issue5
P921main subjectbiomarkerQ864574
P304page(s)1373-1379
P577publication date2014-01-25
P1433published inObesityQ15763232
P1476titleInflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss
P478volume22

Reverse relations

cites work (P2860)
Q88779694Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris
Q35332533Associations between pentraxin 3 and severity of coronary artery disease
Q92592401Bariatric surgery results in restoration of physiological plasma levels of pentraxine-3
Q40590809Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity
Q34547583Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?
Q38380295Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
Q64960673Elevated Pentraxin 3 in Obese Adipose Tissue Promotes Adipogenic Differentiation by Activating Neuropeptide Y Signaling.
Q33650222Inflammatory Long Pentraxin 3 is Associated with Leukocyte Telomere Length in Night-Shift Workers
Q91970155Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality
Q89802634Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients
Q51064056Plasma Pentraxin 3 as a biomarker of metabolic syndrome.
Q39044356Plasma levels of pentraxin 3 in patients with spondyloarthritis
Q59800409The Influence of Pentraxin 3 on the Ovarian Function and Its Impact on Fertility
Q37733630The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation
Q35227705Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
Q47626900Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases

Search more.